These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 8615560)
41. Indomethacin improves survival in gram-negative sepsis. Short BL; Gardiner M; Walker RI; Jones SR; Fletcher JR Adv Shock Res; 1981; 6():27-36. PubMed ID: 6760707 [TBL] [Abstract][Full Text] [Related]
42. Isoproterenol in the treatment of shock due to bacteremia with gram-negative pathogens. Kardos GG N Engl J Med; 1966 Apr; 274(16):868-73. PubMed ID: 17926865 [TBL] [Abstract][Full Text] [Related]
47. TNF-alpha and cyclooxygenase metabolites do not modulate C. albicans septic shock with disseminated candidiasis. Matuschak GM; Klein CA; Tredway TL; Schilly DR; Lechner AJ J Appl Physiol (1985); 1993 May; 74(5):2432-42. PubMed ID: 8335578 [TBL] [Abstract][Full Text] [Related]
48. Hyaluronic acid-decorated reconstituted high density lipoprotein targeting atherosclerotic lesions. Liu L; He H; Zhang M; Zhang S; Zhang W; Liu J Biomaterials; 2014 Sep; 35(27):8002-14. PubMed ID: 24947229 [TBL] [Abstract][Full Text] [Related]
49. Tumor necrosis factor (TNF)-dependent shedding of the p55 TNF receptor in a baboon model of bacteremia. Redl H; Schlag G; Adolf GR; Natmessnig B; Davies J Infect Immun; 1995 Jan; 63(1):297-300. PubMed ID: 7806369 [TBL] [Abstract][Full Text] [Related]
50. [The histopathological effects of different treatments on lung tissue of mice pretreated with cyclophosphamide and steroids in experimental E. coli sepsis]. Düzcan E; Bakir M; Dökmetaş I; Doğanay M; Güneş H Mikrobiyol Bul; 1991 Oct; 25(4):349-59. PubMed ID: 1795659 [TBL] [Abstract][Full Text] [Related]
51. Extremely low doses of tissue factor pathway inhibitor decrease mortality in a rabbit model of septic shock. Matyal R; Vin Y; Delude RL; Lee C; Creasey AA; Fink MP Intensive Care Med; 2001 Aug; 27(8):1274-80. PubMed ID: 11511939 [TBL] [Abstract][Full Text] [Related]
53. Delayed neutralization of interferon-gamma prevents lethality in primate Gram-negative bacteremic shock. Lainée P; Efron P; Tschoeke SK; Elies L; De Winter H; Lorré K; Moldawer LL Crit Care Med; 2005 Apr; 33(4):797-805. PubMed ID: 15818108 [TBL] [Abstract][Full Text] [Related]
54. Systemic and pulmonary reactions in swine with endotoxemia and gram-negative bacteremia. Olson NC; Kruse-Elliott KT; Dodam JR J Am Vet Med Assoc; 1992 Jun; 200(12):1870-84. PubMed ID: 1639692 [No Abstract] [Full Text] [Related]
55. Delayed treatment with recombinant human tissue factor pathway inhibitor improves survival in rabbits with gram-negative peritonitis. Camerota AJ; Creasey AA; Patla V; Larkin VA; Fink MP J Infect Dis; 1998 Mar; 177(3):668-76. PubMed ID: 9498446 [TBL] [Abstract][Full Text] [Related]
56. SOME OBSERVATIONS ON BACTEREMIA DUE TO GRAM-NEGATIVE BACILLI. MARTIN WJ SD J Med Pharm; 1964 Sep; 17():22-30. PubMed ID: 14174188 [No Abstract] [Full Text] [Related]
57. Anti-tumor necrosis factor antibody treatment of recurrent bacteremia in a baboon model. Schlag G; Redl H; Davies J; Haller I Shock; 1994 Jul; 2(1):10-8; discussion 19-22. PubMed ID: 7735979 [TBL] [Abstract][Full Text] [Related]
58. Highly purified vitamin B2 presents a promising therapeutic strategy for sepsis and septic shock. Toyosawa T; Suzuki M; Kodama K; Araki S Infect Immun; 2004 Mar; 72(3):1820-3. PubMed ID: 14977995 [TBL] [Abstract][Full Text] [Related]
59. Aminoglycoside volume of distribution in postoperative patients with septic shock. Oparaoji EC; Cornwell EE; Hekmat E; Lum Cheong R; Adir JS; Siram S Clin Pharm; 1993 Feb; 12(2):131-4. PubMed ID: 8166774 [No Abstract] [Full Text] [Related]
60. Treatment of experimental gram-negative and gram-positive bacterial sepsis with the hematoregulatory peptide SK&F 107647. DeMarsh PL; Wells GI; Lewandowski TF; Frey CL; Bhatnagar PK; Ostovic EJ J Infect Dis; 1996 Jan; 173(1):203-11. PubMed ID: 8537660 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]